Cancer Genetics

Edited by: Paul Smaglik and Eugene Russo R. Scully, J.J. Chen, A. Plug, Y.H. Xiao, D. Weaver, J. Feunteun, T. Ashley, D.M. Livingston, "Association of BRCA1 with Rad51 in mitotic and meiotic cells," Cell, 88:265-75, Jan. 24, 1997. (Cited in more than 235 papers since publication) Comments by David M. Livingston, Emil Frei professor of genetics and medicine, Harvard Medical School, and chairman of the executive committee for research, Dana-Farber Cancer Institute David M. Livingston The tumo

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edited by: Paul Smaglik and Eugene Russo
R. Scully, J.J. Chen, A. Plug, Y.H. Xiao, D. Weaver, J. Feunteun, T. Ashley, D.M. Livingston, "Association of BRCA1 with Rad51 in mitotic and meiotic cells," Cell, 88:265-75, Jan. 24, 1997. (Cited in more than 235 papers since publication)

Comments by David M. Livingston, Emil Frei professor of genetics and medicine, Harvard Medical School, and chairman of the executive committee for research, Dana-Farber Cancer Institute

David M. Livingston The tumor-suppressing ability of the infamous BRCA1 gene--which, along with BRCA2, has been linked to breast cancer1,2--was a complete mystery prior to the findings reported in this paper. Some had speculated that the gene's product served as a growth factor or a hormone. Senior author David M. Livingston and his colleagues at Harvard were the first to give some definitive indication as to where the gene might fit into the biochemical pathway that leads to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies